25I-NB4OMe
![]()  | |
| Clinical data | |
|---|---|
| ATC code | 
  | 
| Legal status | |
| Legal status | 
  | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | 
  | 
| UNII | |
| Chemical and physical data | |
| Formula | C18H22INO3 | 
| Molar mass | 427.282 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
25I-NB4OMe (2C-I-NB4OMe, NB4OMe-2C-I) is a derivative of the phenethylamine hallucinogen 2C-I, which acts as a partial agonist for the human 5-HT2A receptor.[1]
Legality
United Kingdom
This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[2]
References
- ↑ Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Bräuner-Osborne H, Kristensen JL (March 2014). "Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists". ACS Chemical Neuroscience. 5 (3): 243–249. doi:10.1021/cn400216u. PMC 3963123. PMID 24397362.
 - ↑ "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". UK Statutory Instruments 2014 No. 1106. www.legislation.gov.uk.
 
Serotonin receptor modulators  | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-HT1 | 
  | ||||||||||||||||||||||||||||||||||||||
| 5-HT2 | 
  | ||||||||||||||||||||||||||||||||||||||
| 5-HT3–7 | 
  | ||||||||||||||||||||||||||||||||||||||
  | |||||||||||||||||||||||||||||||||||||||
| Phenethylamines | 
 
 
 
 
  | 
|---|---|
| Amphetamines | 
  | 
| Phentermines | 
  | 
| Cathinones | 
  | 
| Phenylisobutylamines | |
| Phenylalkylpyrrolidines | |
| Catecholamines (and close relatives)  | 
  | 
| Miscellaneous | 
  | 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
